The pathophysiology of anti-phospholipid antibodies

P. L. Meroni, A. Tincani, E. N. Harris, G. Valesini, G. R V Hughes, G. Balestrieri

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Anti-phospholipids represent a heterogenous family of antibodies able to react with the negatively charged phosphodiester groups of phospholipids. It includes the antibodies directed against the cardiolipin moiety of the VDRL antigen, the antibodies reacting with the phospholipids of the prothrombin activator complex and the antibodies able to react with solid phase cardiolipin. Data are reported indicating that reagins share distinct characteristics in comparison to the autoimmune anti-cardiolipin antibodies (ACA). On the contrary anti-phospholipid antibodies responsible for lupus-like anticoagulant activity display a quite similar reactivity with ACA, even if a complete overlapping cannot be demonstrated. The relationships between ACA and anti-DNA antibodies are also reported. The biological and clinical significance of these crossreactivities are discussed.

Original languageEnglish
JournalClinical and Experimental Rheumatology
Volume7
Issue numberSUPPL. 3
Publication statusPublished - 1989

Fingerprint

Cardiolipins
Anti-Idiotypic Antibodies
Phospholipids
Antibodies
Reagins
Lupus Coagulation Inhibitor
Antinuclear Antibodies
Prothrombin

ASJC Scopus subject areas

  • Immunology
  • Rheumatology

Cite this

Meroni, P. L., Tincani, A., Harris, E. N., Valesini, G., Hughes, G. R. V., & Balestrieri, G. (1989). The pathophysiology of anti-phospholipid antibodies. Clinical and Experimental Rheumatology, 7(SUPPL. 3).

The pathophysiology of anti-phospholipid antibodies. / Meroni, P. L.; Tincani, A.; Harris, E. N.; Valesini, G.; Hughes, G. R V; Balestrieri, G.

In: Clinical and Experimental Rheumatology, Vol. 7, No. SUPPL. 3, 1989.

Research output: Contribution to journalArticle

Meroni, PL, Tincani, A, Harris, EN, Valesini, G, Hughes, GRV & Balestrieri, G 1989, 'The pathophysiology of anti-phospholipid antibodies', Clinical and Experimental Rheumatology, vol. 7, no. SUPPL. 3.
Meroni PL, Tincani A, Harris EN, Valesini G, Hughes GRV, Balestrieri G. The pathophysiology of anti-phospholipid antibodies. Clinical and Experimental Rheumatology. 1989;7(SUPPL. 3).
Meroni, P. L. ; Tincani, A. ; Harris, E. N. ; Valesini, G. ; Hughes, G. R V ; Balestrieri, G. / The pathophysiology of anti-phospholipid antibodies. In: Clinical and Experimental Rheumatology. 1989 ; Vol. 7, No. SUPPL. 3.
@article{5f404e3656f94410ae148edb271ef699,
title = "The pathophysiology of anti-phospholipid antibodies",
abstract = "Anti-phospholipids represent a heterogenous family of antibodies able to react with the negatively charged phosphodiester groups of phospholipids. It includes the antibodies directed against the cardiolipin moiety of the VDRL antigen, the antibodies reacting with the phospholipids of the prothrombin activator complex and the antibodies able to react with solid phase cardiolipin. Data are reported indicating that reagins share distinct characteristics in comparison to the autoimmune anti-cardiolipin antibodies (ACA). On the contrary anti-phospholipid antibodies responsible for lupus-like anticoagulant activity display a quite similar reactivity with ACA, even if a complete overlapping cannot be demonstrated. The relationships between ACA and anti-DNA antibodies are also reported. The biological and clinical significance of these crossreactivities are discussed.",
author = "Meroni, {P. L.} and A. Tincani and Harris, {E. N.} and G. Valesini and Hughes, {G. R V} and G. Balestrieri",
year = "1989",
language = "English",
volume = "7",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "SUPPL. 3",

}

TY - JOUR

T1 - The pathophysiology of anti-phospholipid antibodies

AU - Meroni, P. L.

AU - Tincani, A.

AU - Harris, E. N.

AU - Valesini, G.

AU - Hughes, G. R V

AU - Balestrieri, G.

PY - 1989

Y1 - 1989

N2 - Anti-phospholipids represent a heterogenous family of antibodies able to react with the negatively charged phosphodiester groups of phospholipids. It includes the antibodies directed against the cardiolipin moiety of the VDRL antigen, the antibodies reacting with the phospholipids of the prothrombin activator complex and the antibodies able to react with solid phase cardiolipin. Data are reported indicating that reagins share distinct characteristics in comparison to the autoimmune anti-cardiolipin antibodies (ACA). On the contrary anti-phospholipid antibodies responsible for lupus-like anticoagulant activity display a quite similar reactivity with ACA, even if a complete overlapping cannot be demonstrated. The relationships between ACA and anti-DNA antibodies are also reported. The biological and clinical significance of these crossreactivities are discussed.

AB - Anti-phospholipids represent a heterogenous family of antibodies able to react with the negatively charged phosphodiester groups of phospholipids. It includes the antibodies directed against the cardiolipin moiety of the VDRL antigen, the antibodies reacting with the phospholipids of the prothrombin activator complex and the antibodies able to react with solid phase cardiolipin. Data are reported indicating that reagins share distinct characteristics in comparison to the autoimmune anti-cardiolipin antibodies (ACA). On the contrary anti-phospholipid antibodies responsible for lupus-like anticoagulant activity display a quite similar reactivity with ACA, even if a complete overlapping cannot be demonstrated. The relationships between ACA and anti-DNA antibodies are also reported. The biological and clinical significance of these crossreactivities are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0024788058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024788058&partnerID=8YFLogxK

M3 - Article

VL - 7

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - SUPPL. 3

ER -